micTruely Your Radio Invalid ID

International

Small risk of severe acute pancreatitis with weight-loss jabs, MHRA says

todayJanuary 29, 2026 1

share close

Agency updates guidance after increase in reports of condition to the yellow card scheme

Patients on weight-loss jabs should be aware there is a small risk of developing severe acute pancreatitis, the UK medicines regulator has said.

About 1.6 million adults in England, Wales and Scotland used GLP-1 medication, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro), between early 2024 and early 2025 to lose weight, according to recent research.

Continue reading…

Source: www.theguardian.com

Read full article

Written by: truelightfm

Rate it

Similar posts

Post comments (0)

Leave a reply

Your email address will not be published. Required fields are marked *